The Australian diagnostic and therapeutic radiopharmaceutical company reported revenue of $220.8 million, driven by growth in prostate cancer imagined agent Illuccix. …
Telix says result reflects its transition to a sustainable commercial-stage company
August 25, 2023 Latest NewsAustralian Biotech
Latest Video
New Stories
-
Canberra is outraged that AI accessed data without asking - others know the feeling
September 24, 2026 - - Latest News -
AbbVie’s top lawyer publicly makes the case against German pricing
September 24, 2026 - - Latest News -
AI is already in the decision-making process, but where is the conversation about its use?
September 24, 2026 - - Latest News -
England's genomics chief to share NHS lessons during Australia visit
September 24, 2026 - - Latest News -
AZ to maintain breast cancer therapy on the PBS for six months despite price rise knocked back
September 24, 2026 - - Latest News -
Blood test for eight cancers arrives in Australia, but misses almost half of them
September 23, 2026 - -
Prescient raises $6 million to carry cancer drug PTX-100 past a key dosing decision
September 23, 2026 - - Australian Biotech